NO20004972L - Derivater av pneumokokkale kolinbindende proteiner for vaksiner - Google Patents

Derivater av pneumokokkale kolinbindende proteiner for vaksiner

Info

Publication number
NO20004972L
NO20004972L NO20004972A NO20004972A NO20004972L NO 20004972 L NO20004972 L NO 20004972L NO 20004972 A NO20004972 A NO 20004972A NO 20004972 A NO20004972 A NO 20004972A NO 20004972 L NO20004972 L NO 20004972L
Authority
NO
Norway
Prior art keywords
choline binding
vaccines
derivatives
binding proteins
pneumococcal
Prior art date
Application number
NO20004972A
Other languages
English (en)
Other versions
NO20004972D0 (no
Inventor
Theresa M Wizemann
Scott Koenig
Leslie Sydnor Johnson
Original Assignee
Medimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Inc filed Critical Medimmune Inc
Publication of NO20004972D0 publication Critical patent/NO20004972D0/no
Publication of NO20004972L publication Critical patent/NO20004972L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
NO20004972A 1998-04-07 2000-10-03 Derivater av pneumokokkale kolinbindende proteiner for vaksiner NO20004972L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8087898P 1998-04-07 1998-04-07
US8574398P 1998-05-15 1998-05-15
PCT/US1999/007680 WO1999051266A2 (en) 1998-04-07 1999-04-06 Derivatives of pneumococcal choline binding proteins for vaccines

Publications (2)

Publication Number Publication Date
NO20004972D0 NO20004972D0 (no) 2000-10-03
NO20004972L true NO20004972L (no) 2000-12-05

Family

ID=26764078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004972A NO20004972L (no) 1998-04-07 2000-10-03 Derivater av pneumokokkale kolinbindende proteiner for vaksiner

Country Status (16)

Country Link
US (3) US6503511B1 (no)
EP (1) EP1067962B1 (no)
JP (1) JP2002510649A (no)
KR (2) KR100794394B1 (no)
CN (1) CN1200731C (no)
AT (1) ATE461709T1 (no)
AU (1) AU766455C (no)
BR (1) BR9909483A (no)
CA (1) CA2325340A1 (no)
DE (1) DE69942176D1 (no)
ES (1) ES2343492T3 (no)
HU (1) HUP0102617A3 (no)
IL (2) IL138798A0 (no)
NO (1) NO20004972L (no)
NZ (2) NZ530277A (no)
WO (1) WO1999051266A2 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
KR100794394B1 (ko) * 1998-04-07 2008-01-15 메디뮨 인코포레이티드 백신용 폐렴 구균의 콜린 결합성 단백질의 유도체
US6858706B2 (en) 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
CN1191851C (zh) * 1998-04-07 2005-03-09 圣朱德儿童研究医院 包含胆碱结合蛋白an－末端截取物的氨基酸的多肽、由该多肽衍生的疫苗及其应用
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
EP1162999B1 (en) 1999-03-19 2006-11-29 Glaxosmithkline Biologicals S.A. Vaccine against Streptococcus pneumoniae
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
AU2001287645A1 (en) * 2000-07-20 2002-02-05 Hansa Medical Ab Fh-binding protein of streptococcus pneumiae
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
US6674504B1 (en) 2000-09-29 2004-01-06 Kent Optronics, Inc. Single layer multi-state ultra-fast cholesteric liquid crystal device and the fabrication methods thereof
PL375408A1 (en) 2002-08-02 2005-11-28 Glaxosmithkline Biologicals S.A. Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
JP2006504801A (ja) 2002-11-01 2006-02-09 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 乾燥方法
ES2346314T3 (es) 2003-10-02 2010-10-14 Glaxosmithkline Biolog Sa Antigenos de b. pertussis y uso de los mismos en vacunacion.
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
US8052971B2 (en) * 2005-11-21 2011-11-08 MG Biologics Oral use of specific antibodies for intestinal health
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
DK3017827T3 (en) 2005-12-22 2019-02-18 Glaxosmithkline Biologicals Sa Pneumococcal polysaccharide conjugate VACCINE
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
KR20080096775A (ko) 2006-01-17 2008-11-03 아르네 포르스그렌 표면 노출된 헤모필루스 인플루엔자 단백질 （단백질 Ｅ ―ｐＥ）
WO2008039838A2 (en) 2006-09-27 2008-04-03 St. Jude Children's Research Hospital Synthetic streptococcus pneumoniae vaccine
WO2009000826A1 (en) 2007-06-26 2008-12-31 Glaxosmithkline Biologicals S.A. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
JP5056490B2 (ja) * 2008-03-10 2012-10-24 富士通株式会社 歪み補償係数更新装置および歪み補償増幅器
KR20110009157A (ko) 2008-04-16 2011-01-27 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
CN102869378A (zh) 2010-03-10 2013-01-09 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
CA2832115C (en) 2011-04-08 2021-03-02 Tufts Medical Center, Inc. Pepducin design and use
SG194733A1 (en) 2011-05-17 2013-12-30 Glaxosmithkline Biolog Sa Vaccine against streptococcus pneumoniae
JP2014000016A (ja) * 2012-06-15 2014-01-09 National Agriculture & Food Research Organization 豚丹毒菌の新規な抗原タンパク質、その遺伝子、及び組換えベクターとその利用
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
CA3005029A1 (en) 2015-11-13 2017-05-18 Oasis Pharmaceuticals, LLC Protease-activated receptor-2 modulators
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
MX2019014829A (es) 2017-06-10 2020-08-17 Inventprise Llc Vacunas de conjugado multivalente con polisacáridos de conjugado bivalente o multivalente que proporcionan inmunogenicidad y avidez mejoradas.
GB201714478D0 (en) * 2017-09-08 2017-10-25 Univ Bristol Sensor

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US6042838A (en) * 1991-02-15 2000-03-28 Uab Research Foundation immunogenic compositions for mucosal administration of pneumococcal surface protein A (PspA)
US5980909A (en) * 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US6027734A (en) * 1991-02-15 2000-02-22 Uab Research Foundation Mucosal administration of pneumococcal antigens
US6231870B1 (en) * 1995-06-02 2001-05-15 Uab Research Foundation Oral administration of pneumoccal antigens
US6232116B1 (en) * 1991-02-15 2001-05-15 University Of Alabama At Birmingham Research Foundation Oral administration of pneumococcal antigens
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US6245335B1 (en) * 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
CA2253252A1 (en) * 1996-05-01 1997-11-06 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
AU6909098A (en) * 1996-10-31 1998-05-22 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
BR9712900A (pt) * 1996-11-06 2000-11-28 Univ California Enzima liberadora de receptor de fator de necrose de tumor isolado, composições que compreendem a enzima e métodos de utilização da mesma
WO1998021337A2 (en) * 1996-11-12 1998-05-22 Regents Of The University Of Minnesota C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
DE19708537A1 (de) 1997-03-03 1998-09-10 Biotechnolog Forschung Gmbh Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc.
US7018637B2 (en) * 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
KR100794394B1 (ko) * 1998-04-07 2008-01-15 메디뮨 인코포레이티드 백신용 폐렴 구균의 콜린 결합성 단백질의 유도체
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
US6936252B2 (en) * 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
WO2000037105A2 (en) * 1998-12-21 2000-06-29 Medimmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
CA2407455A1 (en) * 2000-04-27 2001-11-01 Medimmune, Inc. Immunogenic pneumococcal protein and vaccine compositions thereof
EP2921924B1 (de) * 2014-03-21 2018-09-19 Asco Numatics GmbH Vorrichtung zur Bereitstellung eines Fluids mit geregeltem Ausgangsdruck
US9741151B2 (en) * 2015-04-14 2017-08-22 International Business Machines Corporation Mobile interactive comparison chart

Also Published As

Publication number Publication date
KR20010034752A (ko) 2001-04-25
CA2325340A1 (en) 1999-10-14
AU766455C (en) 2004-12-02
US6503511B1 (en) 2003-01-07
US20050142145A1 (en) 2005-06-30
EP1067962A2 (en) 2001-01-17
WO1999051266A2 (en) 1999-10-14
IL138798A0 (en) 2001-10-31
AU3386999A (en) 1999-10-25
ES2343492T3 (es) 2010-08-02
CN1200731C (zh) 2005-05-11
US20030138447A1 (en) 2003-07-24
US7435421B2 (en) 2008-10-14
NZ507717A (en) 2004-02-27
DE69942176D1 (de) 2010-05-06
HUP0102617A2 (hu) 2001-11-28
JP2002510649A (ja) 2002-04-09
CN1315870A (zh) 2001-10-03
IL138798A (en) 2008-11-03
NO20004972D0 (no) 2000-10-03
HUP0102617A3 (en) 2006-04-28
KR100794394B1 (ko) 2008-01-15
ATE461709T1 (de) 2010-04-15
AU766455B2 (en) 2003-10-16
KR20060126844A (ko) 2006-12-08
EP1067962B1 (en) 2010-03-24
NZ530277A (en) 2005-08-26
BR9909483A (pt) 2001-10-09
US6863893B2 (en) 2005-03-08
WO1999051266A3 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
NO20004972L (no) Derivater av pneumokokkale kolinbindende proteiner for vaksiner
WO2002004496A3 (en) Fimh adhesin proteins and methods of use
NZ512574A (en) Novel streptococcus antigens useful as vaccines
DK0950068T3 (da) Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse
CY1115749T1 (el) Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια
WO2002102974A3 (en) Mutant proteins, high potency inhibitory antibodies and fimch crystal structure
PT815235E (pt) Vacinas para peste
CY1107571T1 (el) Αυξητικος παραγοντας νευρων ως βοηθητικη ουσια εμβολιου
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
CN108135992A (zh) 免疫原性融合蛋白
DE602004028029D1 (en) Rwendung
ATE157258T1 (de) Zubereitungen und behandlungen von pneumonia in tieren
US5807551A (en) Method to provide artificial passive immunity in birds
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
CN100523192C (zh) 来自感染因子的疫苗
PT636030E (pt) Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
BR0001559A (pt) Vacina para a prevenção da colonização de campylobacter em animais, proteìna antigênica de campylobacter, uso de uma proteìna antigênica, vacina para a prevenção da colonização de campylobacter jejuni em galináceos, uso de anticorpos contra uma cepa de campylobacter sem flagelos, ou contra a proteìna antigênica, e, processo para a preparação de uma vacina
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
CY1108761T1 (el) Απενεργοποιημενες κυτοκινες για ανοσοποιηση
BR0110791A (pt) Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo
TR200003722T2 (tr) Aşılar için pnömokokal kolin bağlayıcı protein türevleri
TH14996EX (th) วัคซีนป้องกันโรคติดเชื้อสเตร็ปโตคอคคัส ซูอิส
TH74105A (th) วิธีการรวมแอนติเจนเข้าในเวสิเคิลที่เมมเบรนด้านนอกของแบคทีเรียและสูตรผสมที่ได้

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application